The global single-use bioprocessing connectors market size is estimated to reach USD 4.9 billion by 2033, expanding at a CAGR of 14.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market growth can be attributed to several key factors, including the increasing adoption of single-use bioprocessing assemblies, rising biologics and biosimilar production, and technological advancements in connector designs.
Single-use bioprocessing connectors reduce costs associated with cleaning validation, equipment maintenance, and downtime between production batches. Faster setup times and simplified workflows enhance overall productivity in biologics manufacturing. Hence, the benefits such as reduced cleaning validation, faster turnaround times, and lower risk of cross-contamination have led to an industry shift from traditional stainless-steel bioprocessing to single-use technologies, which has significantly boosted demand for single-use connectors.
Moreover, regulatory agencies such as the FDA, EMA, etc. emphasize contamination control and sterility assurance, boosting demand for high-performance aseptic connectors. Connectors with secure, leak-proof, and closed-system designs are crucial in ensuring sterility. Additionally, the rise of modular bioprocessing facilities and flexible manufacturing requires adaptable single-use bioprocessing connectors that allow quick changeovers.
Furthermore, the expansion of Contract Manufacturing Organizations (CMOs/CDMOs) drives the demand for single-use technologies such as connectors. They require flexible and cost-effective solutions like single-use bioprocessing connectors to accommodate diverse client needs and varying batch sizes.
However, extractable & leachable concerns related to single-use bioprocessing connectors may lead to product contamination and reduced drug efficacy or altered stability. Regulatory scrutiny, as agencies like the FDA and EMA require rigorous E&L testing. This factor may limit the use of disposable connectors to a certain extent.
Request a free sample copy or view report summary: Single-use Bioprocessing Connectors Market Report
Based on product, the aseptic connectors segment held the largest market share in 2025. They are designed to maintain a sterile connection between fluid paths and are widely used in biologics, vaccine production, and cell & gene therapy.
Based on application, the upstream bioprocessing segment dominated the market in 2025. Single-use bioprocessing connectors are widely used in upstream processes such as media preparation, cell culture, fermentation, and feed transfer.
Based on end use, the biopharmaceutical & pharmaceutical companies segment dominated the market in 2025. The pharmaceutical and biopharmaceutical industries are witnessing substantial growth in the single-use bioprocessing connectors market, driven by the rising demand for advanced therapies.
The North America region dominated the market share of 47.2% in 2025. The dominant market share of the region can be attributed to the expansion of the biotechnology and pharmaceutical industries, advancements in product development, and the rising prevalence of diseases like cancer. Additionally, increased investments and funding in drug discovery research further drive market growth.
Grand View Research has segmented the global single-use bioprocessing connectors market report based on product, application, end use, and region:
Single-use Bioprocessing Connectors Product Outlook (Revenue, USD Billion, 2021 - 2033)
Aseptic Connectors
Tube-to-tube connectors
Tube-to-bag connectors
Genderless sterile connectors
High-flow aseptic connectors
Conventional Connectors
Luer-based systems
Hose barb connectors
Quick disconnects
Connector-Integrated Tubing Interfaces
Pre-attached tubing connector systems
Tubing-compatible sterile interfaces
Integrated fluid transfer connection sets
Single-use Bioprocessing Connectors Application Outlook (Revenue, USD Billion, 2021 - 2033)
Upstream Bioprocessing
Downstream Bioprocessing
Fill-finish Operations
Fluid Transfer & Sampling Applications
Single-use Bioprocessing Connectors End Use Outlook (Revenue, USD Billion, 2021 - 2033)
Biopharmaceutical & Pharmaceutical Companies
CMOs / CDMOs
OEM & Assembly Integrators
Academic & Research Institutes
Single-use Bioprocessing Connectors Regional Outlook (Revenue, USD Billion, 2021- 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Single-use Bioprocessing Connectors Market
Sartorius AG
Merck KGaA
Danaher Corporation
Saint-Gobain Life Sciences
Colder Products Company
Thermo Fisher Scientific Inc.
Avantor Inc.
Foxx Life Sciences
Repligen Corporation
Entegris Inc.
Nordson Corporation
Eldon James
Watson-Marlow Fluid Technology Solutions
Savillex
"The quality of research they have done for us has been excellent..."